Oasis Medical Recalls ImproVue Ophthalmic Lubricant Drops for pH Failure
Oasis Medical is recalling specific lots of ImproVue Ophthalmic Lubricant Drops because they failed to meet pH specifications.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The recall is classified as FDA Class III, which the rubric defines as typically resulting in a score of 1 or 2 because it is unlikely to cause adverse health consequences.
Plain-English summary
Oasis Medical, Inc. is recalling 9,731 cartons of ImproVue Ophthalmic Lubricant Drops (1.7% Hypromellose). The affected product is a single-use syringe containing 0.07 fl oz (2mL) of solution, manufactured for OCULUS SURGICAL in Port St. Lucie, FL. The recall covers specific lots with expiration dates of 02/16 and 04/16.
The recall was initiated because the product failed to meet pH specifications. This is an FDA Class III recall, which indicates that the violation is not likely to cause adverse health consequences.
Consumers who have this product should stop using it and contact the manufacturer or their healthcare provider for further instructions.
The recalled product
- Product
- ImproVue Ophthalmic Lubricant Drops (1.7% Hypromellose), 1 Single Use Syringe, 0.07 fl oz (2mL), 1 Single Use Applicator Tip per carton, Manufactured for OCULUS SURGICAL, Port St. Lucie, FL 34986, NDC 62144-5510-05
- Manufacturer
- Oasis Medical, Inc.
- Category
- Drug — Ophthalmic
- Hazard
- Affected units
- 9,731
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot# V0814B
- Exp 02/16
- V1014H
- Exp 04/16
Distribution
Distributed in 1 state:
Related recalls
Same manufacturer · Oasis Medical, Inc.
See all →- SevereOasis Tears PF Lubricant Eye Drops Recalled for Sterility Assurance
FDA (Drugs) · 2026-05-20
- LowOasis Medical Recalls HPMC Visoelastic Topical Due to pH Specification Failure
FDA (Drugs) · 2015-12-30
- LowOasis Medical Recalls HPMC Visoelastic Due to Potential pH Specification Failure
FDA (Drugs) · 2015-12-30
- LowOasis Medical Recalls HPMC Visoelastic Due to pH Specification Failure
FDA (Drugs) · 2015-12-30
- LowOasis Medical Recalls ImproVue Ophthalmic Drops for pH Specification Failure
FDA (Drugs) · 2015-09-16
Same hazard · ph failure
See all →- ModerateDiclofenac topical gel recalled after failing pH specifications
FDA (Drugs) · 2026-01-28
- LowFerring Recalls Menopur Due to Out-of-Specification pH in Diluent
FDA (Drugs) · 2021-03-17
- SevereAuroMedics Recalls Acetaminophen Injection Due to Discoloration and pH Failures
FDA (Drugs) · 2021-02-10
- ModerateHikma Recalls Sodium Chloride Injection Vials Due to pH Failures
FDA (Drugs) · 2020-12-23
- ModerateHikma Recalls Sodium Chloride Injection Vials Due to pH Failures
FDA (Drugs) · 2020-11-25